Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Livetiles Ltd, led by Matthew Brown, specializes in digital workplace solutions leveraging AI and user-friendly interfaces.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
LiveTiles is managed by CEO David Vander.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Advancing Aeronautical Sustainability: Insights from Bombardier CEO | Éric Martel - CEO of Bombardier Inc.
00:10:00
committed to building sustainable high impact businesses|Daniel Jhin Yoo,Founder,Long Term Impact
00:10:00
Exploration Potential of E2 Gold's Hawkins Project in Ontario, Canada
00:10:00
Koen Dejonckheere on Strategic Investments and Global Technological Trends | Koen Dejonckheere, CEO, GIMV Corporate.
00:10:00
Tim Heenan, Interim President at Mirasol Resources: Company Overview and Exploration Focus
00:10:00
Franchise Brands PLC Executive Chairman Stephen Hemsley reflects on the decade since he and co-founder Nigel Wray initiated their entrepreneurial journey.
00:10:00
Quadria Capital’s Amit Varma on Raising a Second Healthcare Fund and Industry Trends | Amit Varma, Managing Partner, Quadria Capital.
00:10:00
Peruvian Mining Supplier Registration Procedure | Santiago Montt V. - Founder , CEO of Montt Group Inc.
00:10:00
The Age of Reagan: Uniting Foreign Policy and Domestic Vision|Steven Hayward
00:00:00
Wade Harper, Ph.D. Bert and Natalie Vallee Professor of Molecular Pathology (HMS) | Our Cells' Molecular Machines
00:10:00
The Foundry Advantage: Investing in Founders, Not Just Businesses|Brad Feld,Co-Founder & Partner,Foundry Group
00:10:00
Retirement Planning Insights: Allodium Investment Consultants | David J. Bromelkamp - CEO of Allodium Investment Consultants